Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.17.580812Source: DataRank Database

Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.191. It has been cited 2 times, with 2 citing works in its 1-hop citation network.

N/A

0.191DataRank · unranked

Scored on demand from live citation data

Open Access2 citations · 2 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: greenTopics (3)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 86%Citation Network 14%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

0.0267

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 2 citers.

Bioinformatics analysis of JUP in patients with acute myocardial infarction and its potential application in clinical prognostic evaluation
Frontiers in Cardiovascular Medicine20252 citations35 referencesContributes 0.031
Novel Drug Targets for Nonischaemic Cardiomyopathy Identified by Integrated Proteomic and Genomic Analysis
SSRN Electronic Journal20240 citations59 referencesContributes 0.000

Authors (15)

Abigail Kelly,Weicang Wang ORCID,Jun Yang ORCID,Sung Hee Hwang ORCID,Michael Allen Gillespie

Live enrichment

PubMed:38463975

National Institutes of Health

Grant: 5R35ES030443-04

Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases

National Institutes of Health

Grant: 5P42ES004699-30

Biomarkers of Exposure to Hazardous Substances

National Institutes of Health

Grant: 5P30AR073752-02

Washington University Rheumatic DiseasesResearch Resource-based Center

National Institutes of Health

Grant: 5R35HL161185-04

Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure

European Commission

Grant: 276107

Assessing the effect of early social environment on epigenetic modification

National Institutes of Health

Grant: 1R01CA276107-01A1

Control of cancer cachexia via stimulation of resolution of inflammation

National Institutes of Health

Grant: 3U54NS127758-02S1

UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication

National Institutes of Health

Grant: 5R01HL148348-04

Arrhythmogenic Cardiomyopathy is an Inflammatory Disease

National Institutes of Health

Grant: 5T32AI007163-44

Training Program in Immunology

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/02/19/2024.02.17.580812.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.02.17.580812

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10925075/pdf/nihpp-2024.02.17.580812v1.pdf

https://doi.org/10.1101/2024.02.17.580812

https://pubmed.ncbi.nlm.nih.gov/38463975